Published in

Elsevier, Nuclear Medicine and Biology, 2(42), p. 78-84

DOI: 10.1016/j.nucmedbio.2014.09.011

Links

Tools

Export citation

Search in Google Scholar

Preclinical pharmacokinetics, biodistribution, radiation dosimetry and acute toxicity studies required for regulatory approval of a Clinical Trial Application for a Phase I/II clinical trial of 111In-BzDTPA-pertuzumab

Journal article published in 2015 by Karen Lam, Conrad Chan, Susan J. Done ORCID, Mark N. Levine, Raymond M. Reilly
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Red circle
Postprint: archiving forbidden
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO